Furthermore, a positive correlation between Foxp3+ CD4+ T-cells frequency, among the PBMCs and the CCL22 plasmatic levels, has been reported in the asymptomatic carriers and in chronic ATLL patients [136]. This evidence concerns the gene FOXP3 and adult T-cell leukemia/lymphoma.